Welcome to the June 2022 Edition of Sepsis Chatter! Our newest video presentation is titled: “Severe Sepsis, Septic Shock and Infection: Abstracting the Earliest Documented Time from One Provider Note” This presentation begins with a review of determining when severe sepsis is present using provider documentation only and severe sepsis present met by clinical criteria. In addition, we will review the four common challenges related to…
Worldwide, Total Mesorectal Excision (TME) has become the gold standard treatment for middle and lower rectal cancer. Studies have demonstrated a TME improves local recurrence rates and the corresponding survival by as much as 20%. High-quality TME surgery reduces local recurrence from 20% to 30% and increases 5-year survival from 48% to 68%. The June 2022 CTR Coding Break titled ‘STORE Manual 2022 Macroscopic Mesorectum’ discusses…
The May 2022 CTR Coding Break titled First Course vs Subsequent Treatment discusses first course and second course treatment standard setter definitions, the differences between the two courses as well as a few case examples. First course treatment is the initial plan of treatment, includes any modality of treatment and may last a year or more. First course treatment has an ending point with different scenarios…
